Stay updated with breaking news from Patient Dosing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patient Dosing and Enrollment Continue to Progress in Beacon Phase 1/2 Study of BEAM-101 in Severe Sickle Cell Disease; First Clinical Data Anticipated in Second Half of 2024
Patient Dosing and Enrollment Continue to Progress in Beacon Phase 1/2 Study of BEAM-101 in Severe Sickle Cell Disease; First Clinical Data Anticipated in Second Half of 2024 Phase 1 Trial Initiation...
Investegate announcements from Syncona Limited, Achilles reports Full Year 2021 Results
The FDA's statistics show that this can significantly reduce overall development times which impacts time to market.